B

Biovaxys Technology Corp
OTC:BVAXF

Watchlist Manager
Biovaxys Technology Corp
OTC:BVAXF
Watchlist
Price: 0.0271 USD -1.45%
Market Cap: 6m USD

Intrinsic Value

BVAXF doesn't have a meaningful market cap.
BVAXF's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one BVAXF stock under the Base Case scenario is 0.0003 USD. Compared to the current market price of 0.0271 USD, Biovaxys Technology Corp is Overvalued by 99%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BVAXF Intrinsic Value
0.0003 USD
Overvaluation 99%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation History
Biovaxys Technology Corp

Valuation History Unavailable

Historical valuation for BVAXF cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare BVAXF to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BIOV?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Biovaxys Technology Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biovaxys Technology Corp

Current Assets 1.3m
Cash & Short-Term Investments 157.4k
Receivables 468.2k
Other Current Assets 655.7k
Efficiency

Free Cash Flow Analysis
Biovaxys Technology Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Biovaxys Technology Corp

Revenue
0 CAD
Operating Expenses
-4.1m CAD
Operating Income
-4.1m CAD
Other Expenses
-1.4m CAD
Net Income
-5.5m CAD
Fundamental Scores

BVAXF Profitability Score
Profitability Due Diligence

Biovaxys Technology Corp's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional ROE
Exceptional ROIC
ROE is Increasing
57/100
Profitability
Score

Biovaxys Technology Corp's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

BVAXF Solvency Score
Solvency Due Diligence

Biovaxys Technology Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
42/100
Solvency
Score

Biovaxys Technology Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BVAXF Price Targets Summary
Biovaxys Technology Corp

There are no price targets for BVAXF.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Biovaxys Technology Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for BIOV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one BVAXF stock?

The intrinsic value of one BVAXF stock under the Base Case scenario is 0.0003 USD.

Is BVAXF stock undervalued or overvalued?

Compared to the current market price of 0.0271 USD, Biovaxys Technology Corp is Overvalued by 99%.

Back to Top